Coherus Biosciences Inc (NASDAQ:CHRS) does about 1.64M shares in volume on a normal day but saw 3982214 shares change hands in Tuesday trading. The company now has a market cap of 159.47M USD. Its current market price is $1.39, marking a decrease of -13.66% compared to the previous close of $1.61. The 52 week high reached by this stock is $5.47 whilst the lowest price level in 52 weeks is $1.43.
Coherus Biosciences Inc (CHRS) has a 20-day trading average at $1.6815 and the current price is -74.57% off the 52-week high compared with -2.80% distance from its 52-week low. The 50-day simple moving average of the closing price is $1.9048 and its 200-day simple moving average is $2.4770. If we look at the stock’s price movements over the week, volatility stands at 9.36%, which decreases to 6.65% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 29.96 to suggest the stock is oversold.
The consensus objective for the share price is $9.00, suggesting that the stock has a potential upside of 84.56% over the period.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on November 17, 2023 when Robert W. Baird initiated the stock to “Outperform” and issued a price target of $11. Citigroup initiated its price target at $12.
Coherus Biosciences Inc (CHRS) stock is down -12.03% over the week and -23.63% over the past month. Its price is -58.26% year-to-date and -67.45% over the past year.
To reach the target analysts have set, the stock logically needs to grow 84.56 percent from here.
The company has a return on investment of -26.65%. The beta has a value of 0.60. Price to sales ratio is 0.53.
